Although biosimilars have been part of clinical practice for more than a decade, healthcare
professionals (HCPs) do not fully accept them. This is because of the perception that …

Importance Biosimilar drugs provide cost-effective yet clinically indistinguishable
replications of target drugs. During initial development, this class of biologic medicines was …

Background Pharmacists being the drug experts need to be well aware of the applied
handling of biosimilar medicines (BSMs). They are an integral educator, trailblazer, and …

Background The adoption of oncology biosimilars has been slow in the USA, which may be
attributed in part to stakeholder perceptions and lack of operational guidance that supports …

Objectives Pharmacists are drug experts who can play a significant role in promoting the use
of biosimilar medicines. Therefore, the aim of this study was to assess community …

Aim: We aimed to improve oncology patients' knowledge and awareness of biosimilars.
Subsequently, we conducted an assessment of this knowledge by use of an anonymous …

Formulary management systems in hospitals and health‐systems serve to ensure that
medications are rigorously evaluated for efficacy, safety, and value. The increased …

Introduction To evaluate biosimilar understanding and preference trends of medical
oncologists in Turkey. Methods A survey consisting of 24 multiple-choice questions with …

Background: As the cost of cancer care continues to rise, biosimilars provide an important
cost-saving treatment option. Thus, understanding barriers to biosimilar uptake, including …

Background Biosimilars have been adopted by clinicians more slowly than anticipated in the
post-marketing phase. Objectives We aimed to reveal the perceptions and attitudes of …